Cad is brí le “Soiléir”?
Ní iompraíonn an t-ainmhí an sóchán. Ní dhéanfaidh sé an galar a fhorbairt agus ní chuirfidh sé ar aghaidh é.
Centronuclear Myopathy (CNM) is a genetic disorder affecting Border Collies, characterized by muscle weakness and exercise intolerance. A DNA test for CNM is essential for responsible breeding, helping to identify carriers and reduce the risk of this debilitating condition. This simple yet effective test enables dog owners and breeders to make informed decisions, ensuring healthier puppies. By understanding the genetic predisposition to CNM, owners can provide better care and management for affected dogs. Regular screening through DNA testing not only promotes the health of individual dogs but also contributes to the overall well-being of the Border Collie breed. Invest in a CNM DNA test today to safeguard your canine companion’s future.
Centronuclear Myopathy (CNM) is a genetic disorder affecting Border Collies, characterized by muscle weakness and exercise intolerance. A DNA test can identify carriers and affected dogs, enabling breeders to make informed decisions to reduce the prevalence of this condition. Early detection through genetic testing can help owners manage symptoms and improve the quality of life for affected pets. Responsible breeding practices based on test results play a crucial role in preserving the health of the breed. Overall, DNA testing for CNM enhances breed welfare and promotes healthier generations of Border Collies.
Tá an tástáil DNA seo san áireamh ag tosú ónár bpacáiste Basic — agus tá sé mar chuid de na pacáistí freisin Basic, Standard, Advanced, Complete.
Féach ar Pacáistí Tástála DNA →Centronuclear Myopathy (CNM) is a hereditary muscle disorder found in Border Collies. Characterized by weakness and muscle atrophy, this genetic condition significantly affects the dog's motor capabilities and overall quality of life. CNM results from mutations in specific genes leading to improper muscle fiber development and function.
Dogs affected by CNM typically exhibit clinical signs from a young age. Common symptoms include muscle weakness, reduced physical activity, exercise intolerance, abnormal gait, and muscle wasting. Severely affected dogs may have difficulty standing or walking, potentially impacting their ability to perform routine daily activities.
CNM in Border Collies is inherited in an autosomal recessive manner. This means a dog must inherit two copies of the mutated gene—one from each parent—to exhibit symptoms. Dogs carrying only one copy of the mutation (carriers) do not typically show signs but can pass the mutation onto offspring.
DNA testing is essential for identifying the CNM mutation in Border Collies. Early identification of affected and carrier dogs helps breeders make informed decisions, preventing the spread of the condition. DNA testing enables responsible breeding practices, assisting in reducing and eventually eliminating the occurrence of this debilitating condition.
The DNA test clearly distinguishes three genetic statuses:
Breeders are advised to conduct CNM DNA testing in breeding dogs before mating. Clear mating strategies should be selected to avoid producing affected puppies. Owners of Border Collies should consult veterinarians and genetic specialists for guidance on managing dogs diagnosed with CNM, ensuring the best possible quality of life.
Ní iompraíonn an t-ainmhí an sóchán. Ní dhéanfaidh sé an galar a fhorbairt agus ní chuirfidh sé ar aghaidh é.
Tá an t-ainmhí sláintiúil go ginearálta ach is féidir leis an sóchán a tharchur chuig a sliocht.
Tá dhá chóip mutated ar iompar aige. Táthar ag súil le comharthaí cliniciúla ag brath ar an galar. Níor chóir é a phóraítear.
Tá roinnt galair ceangailte le gnéas, mar sin athraíonn a léiriú ag brath ar an gnéas ainmhí.
This DNA test detects the mutation associated with Centronuclear Myopathy In Border Collie (CNM) in order to identify clear, carrier, or at-risk animals.
Cuidíonn tástáil DNA le póraitheoirí cúplála níos sábháilte a phleanáil agus an baol go dtarchuirfear an sóchán chuig an sliocht a laghdú.
Is é Autosomal Recessive an modh oidhreachta a thuairiscítear don tástáil seo.
This test analyses the mutation DNM2 c.1393C>T.
Ní gá. Braitheann an léirmhíniú ar an bpatrún oidhreachta agus ar an géinitíopa dá bharr.
Böhm Johann, Barthélémy Inès, Landwerlin Charlène, BlanchardGutton Nicolas, Relaix Frédéric, Blot Stéphane, Laporte Jocelyn, Tiret Laurent. A dog model for centronuclear myopathy carrying the most common DNM2 mutation. Dis Model Mech. 2022 Apr 1;15(4):dmm049219. doi: 10.1242/dmm.049219. Epub 2022 Apr 14.
Do phríobháideachas, do rogha
Bainimid úsáid as fianáin riachtanacha chun an suíomh Gréasáin a rith. Díchumasaítear fianáin roghnacha (cosúil le soláthraithe ábhair leabaithe) de réir réamhshocraithe agus ní chuirtear ar chumas iad ach amháin má aontaíonn tú. Is féidir leat do rogha a athrú am ar bith agus an cnaipe “Fianáin” á úsáid agat.
Ag teastáil le haghaidh gnéithe lárnacha agus slándála. Cumasaithe i gcónaí.
Feabhsaítear gnéithe mar shábháil tosaíochta nó leabaithe neamhfhógraíochta.
Cuidíonn sé linn úsáid láithreáin a thuiscint. Díchumasaithe de réir réamhshocraithe.
Fógraíocht/rianú trasna suíomhanna (leabaíonn roinnt fístéipeanna/léarscáileanna). Díchumasaithe de réir réamhshocraithe.